Administration of Radioactive Substances Advisory Committee

Last updated

Administration of Radioactive Substances Advisory Committee
Administration of Radioactive Substances Advisory Committee logo.svg
Type non-departmental public body
Website www.gov.uk/government/organisations/administration-of-radioactive-substances-advisory-committee

The Administration of Radioactive Substances Advisory Committee (ARSAC) is an advisory non-departmental public body of the government of the United Kingdom. It is sponsored by the Department of Health.

Contents

The committee advises government on the certification of doctors and dentists who want to use radioactive medicinal products on people.

Doctors and dentists who use radioactive medicinal products (radiopharmaceuticals) on people must get a certificate from health ministers. This certificate allows them to use radioactive medicinal products in diagnosis, therapy and research.

ARSAC was set up to advise health ministers with respect to the grant, renewal, suspension, revocation and variation of certificates and generally in connection with the system of prior authorisation required by Article 5(a) of Council Directive 76/579/Euratom.

The majority of ARSAC's members are medical doctors who are appointed to the committee as independent experts in their field (for example nuclear medicine). The committee comments on applications in confidence to the ARSAC Support Unit, Public Health England. No individual committee member approves any single application.

An official from the Department of Health authorises successful applications on behalf of the Secretary of State.

See also

Related Research Articles

Health Canada is the department of the Government of Canada responsible for national health policy. The department itself is also responsible for numerous federal health-related agencies, including the Canadian Food Inspection Agency (CFIA) and the Public Health Agency of Canada (PHAC), among others. These organizations help to ensure compliance with federal law in a variety of healthcare, agricultural, and pharmaceutical activities. This responsibility also involves extensive collaboration with various other federal- and provincial-level organizations in order to ensure the safety of food, health, and pharmaceutical products—including the regulation of health research and pharmaceutical manufacturing/testing facilities.

Minister of Health (Canada)

The minister of health is the minister of the Crown in the Canadian Cabinet who is responsible for overseeing health-focused government agencies including Health Canada and the Public Health Agency of Canada, as well as enforcing the Canada Health Act, the law governing Canada's universal health care system. The current minister is Jean-Yves Duclos.

Radiopharmacology Pharmacologic study of radiated medical compounds

Radiopharmacology is radiochemistry applied to medicine and thus the pharmacology of radiopharmaceuticals. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases. Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide. In the book Technetium a total of 31 different radiopharmaceuticals based on Tc-99m are listed for imaging and functional studies of the brain, myocardium, thyroid, lungs, liver, gallbladder, kidneys, skeleton, blood and tumors.

Regulation of therapeutic goods Legal management of drugs and restricted substances

The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as in Australia.

European Medicines Agency Agency of the European Union

The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of medicinal products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency (EMEA).

Medicines and Healthcare products Regulatory Agency Medicine regulation agency in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.

The Veterinary Medicines Directorate (VMD) is an Executive Agency of the Department for Environment, Food and Rural Affairs (Defra) seeking to protect public health, animal health, the environment and promoting animal welfare by assuring the safety, quality and efficacy of veterinary medicines in the United Kingdom.

The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom. It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

Kamlesh Patel, Baron Patel of Bradford

Kamlesh Kumar Patel, Lord Patel of Bradford, OBE is a member of the House of Lords. Having been appointed an Officer of the Order of the British Empire (OBE) in the 1999 Birthday Honours, he was created a life peer as Baron Patel of Bradford, of Bradford in the County of West Yorkshire on 8 June 2006.

The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.

European Directorate for the Quality of Medicines & HealthCare International organisation

The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a Directorate of the Council of Europe that traces its origins and statutes to the Convention on the Elaboration of a European Pharmacopoeia.

The Commission on Human Medicines (CHM) is a committee of the UK's Medicines and Healthcare products Regulatory Agency. It was formed in October 2005, and assumed the responsibilities of the Medicines Commission and the Committee on Safety of Medicines. Membership in this various and extensive body is listed on a governmental website.

An experimental drug is a medicinal product that has not yet received approval from governmental regulatory authorities for routine use in human or veterinary medicine. A medicinal product may be approved for use in one disease or condition but still be considered experimental for other diseases or conditions. In 2018 the United States of America signed the legislation "Right to Try", this allows individuals who fit into the criteria to try experimental drugs that are not yet deemed safe.

Regulation and prevalence of homeopathy Alternative medicine

Homeopathy is fairly common in some countries while being uncommon in others. In some countries, there are no specific legal regulations concerning the use of homeopathy, while in others, licenses or degrees in conventional medicine from accredited universities are required.

Executive agency Part of a UK government department

An executive agency is a part of a government department that is treated as managerially and budgetarily separate, to carry out some part of the executive functions of the United Kingdom government, Scottish Government, Welsh Government or Northern Ireland Executive. Executive agencies are "machinery of government" devices distinct both from non-ministerial government departments and non-departmental public bodies, each of which enjoy a real legal and constitutional separation from ministerial control. The model was also applied in several other countries.

The Pharmacy and Poisons Board is the Drug Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya.

National Commission for Radiation Protection of Ukraine

The National Commission for Radiation Protection of Ukraine(NCRPU) is a permanent independent collegial supreme scientific expert advisory and consultative body to the Verkhovna Rada on matters of radiation protection and radiation safety of Ukraine. Its composition is being coordinated through the National Academy of Sciences of Ukraine.

The Worker Protection Standard is intended to protect employees on farms, forests, nurseries, and greenhouses that are occupationally exposed to agricultural pesticides.

Because of the uncertain nature of various alternative therapies and the wide variety of claims different practitioners make, alternative medicine has been a source of vigorous debate, even over the definition of "alternative medicine". Dietary supplements, their ingredients, safety, and claims, are a continual source of controversy. In some cases, political issues, mainstream medicine and alternative medicine all collide, such as in cases where synthetic drugs are legal but the herbal sources of the same active chemical are banned.

The Australian Technical Advisory Group on Immunisation (ATAGI) is a technical advisory group of the Australian Government. As part of the Department of Health, ATAGI provides advice to the Minister of Health on the immunisation program of Australia and related matters, including the strength of evidence pertaining to existing, new, and emerging vaccines.

References